Haematological cancers: improving outcomes. A summary of updated NICE service guidance in relation to Specialist Integrated Haematological Malignancy Diagnostic Services (SIHMDS).

Article English OPEN
Snowden, J.A.; O'Connell, S.; Hawkins, J.; Dalley, C.; Jack, A.; Mannari, D.; McNamara, C.; Scott, M.; Shenton, G.; Soilleux, E.; Macbeth, F.;
(2017)
  • Publisher: BMJ Publishing Group

Haematological malignancies are a diverse group of cancers that affect the blood, bone marrow and lymphatic systems. Laboratory diagnosis of haematological malignancies is dependent on combining several technologies, including morphology, immunophenotyping, cytogenetics... View more
  • References (20)
    20 references, page 1 of 2

    1.National Institute for Health and Care Excellence (2016) Haematological cancers: improving outcomes (NG47). www.nice.org.uk/guidance/ng47

    2.WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. WHO/IARC Classification of Tumours, 4th Edition, 2008

    3.Swerdlow S et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood 2016; 127 (20):2375

    4.Arber D et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 2016; 127 (20):2391

    5.LaCasce A et al. Potential impact of pathologic review on therapy in non-Hodgkin's lymphoma (NHL): Analysis from the national comprehensive cancer network (NCCN) NHL outcomes project. Blood. 2005;106 (11):789A.

    6.Lester JF et al. The clinical impact of expert pathological review on lymphoma management: a regional experience. British Journal of Haematology. 2003;123(3):463-8.

    7.Proctor IEM,et al. Importance of expert central review in the diagnosis of lymphoid malignancies in a regional cancer network. Journal of Clinical Oncology. 2011;29(11):1431-5.

    8. National Institute for Clinical Excellence (2003) Improving outcomes in haemato-oncology cancer (CSG3) www.nice.org.uk/guidance/csg3

    9.Bowen JM et al. Lymphoma diagnosis at an academic centre: Rate of revision and impact on patient care. British Journal Haematology. 2014;166 (2):202-8.

    10. Chang C et al. Hematopathologic discrepancies between referral and review diagnoses: A gap between general pathologists and hematopathologists. Leukaemia and Lymphoma. 2014;55 (5):1023-30.

  • Metrics
Share - Bookmark